Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Leaders in Biobanking Congress 2014, September 15-17, 2014 | Seattle, WA| Healthtech.com/Biobanking 

Reporter: Aviva Lev-Ari, PhD, RN

 

FINAL AGENDA ANNOUNCEMENT

 

Leaders in Biobanking Congress 2014                       

September 15-17, 2014 | Seattle, WA| Healthtech.com/Biobanking 

Register by May 30th & SAVE! | Download Conference Brochure

 

Today, biospecimen collections are used by multiple research groups for varying research aims, from basic

research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological

research. The proper collection, processing, storage and tracking of biospecimens are critical components

allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is

both a science and a business. Cambridge Healthtech Institute’s Sixth Annual Leaders in Biobanking Congress:

 Maximizing Your Investment in Biospecimens addresses both the business and science of biobanking, bringing

together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners

to investigate the best strategies for effective use of biospecimens within  today’s cutting edge research.

Topics Include:

 

Plenary Keynote Presentations on Defining Precision Medicine – It Takes a Village, – in which four speakers

emphasize the diverse insights, broad resources and expansive collaborations needed to meet the promise of this field:

• Dr. Carolyn Compton of National Biomarkers Development Alliance and Arizona State University
• Dr. James Olson of Seattle Children’s Hospital and Presage Biosciences
• Dr. Nathan Price of the Institute for Systems Biology
• Dr. John Slattery of University of Washington School of Medicine

Biobanking Is a Business, which highlights costs, resource optimization, self-sustainability and other issues

managers must consider to run successful biorepositories

Informed Consent: Biosamples Start with Patients, which considers how to balance scientific utility with

individual privacy, with examples on iPSC research, pediatric biobanking and unexpected results

Putting Biosamples to Use, which emphasizes connections between good biobanking practices and biomarker

development, translational research and personalized medicine  Optimizing Value from Your Biospecimens, which offers insights on improving quality, biobanking informatics and global infrastructures for that purpose Biospecimen Processing and Storage Optimization, which explores temperature control, freeze-thaw effects, stabilization and other important factors that affect the quality of bio-and cryopreserved samples  Case Study Presentations, which illustrate active Biobanker/Biouser Partnerships and each party’s needs, contributions, bottlenecks and scientific results

Confirmed Speakers Include:

• Cary D. Austin, M.D., Ph.D., D.A.B.P., Pathologist, Pathology, gRED, Genentech, Inc.
• Geoffrey Baird, M.D., Ph.D., Assistant Professor, Laboratory Medicine, University of Washington
• Stefano Begolo, Ph.D., Research Scientist, Rustem F. Ismagilov Laboratory, Division of Chemistry and Chemical Engineering, California Institute of Technology

• Andrew Brooks, Ph.D., COO, RUCDR Infinite Biologics; Associate Professor, Genetics, Rutgers University
• Wylie Burke, M.D., Ph.D., Professor, Bioethics and Humanities, University of Washington
• Carolyn Compton, M.D., Ph.D., CMO, National Biomarkers Development Alliance and Professor, School of Life Sciences, Arizona State University
• Hoda Elgendy, Ph.D., CSO, BioActive Technologies, Inc.
• Donna Farley, Associate Consultant, Eli Lilly and Company
• Dayong Gao, Ph.D., Professor, Mechanical Engineering and Bioengineering, University of Washington
• Allison Hubel, Ph.D., Professor, Mechanical Engineering and Director, Biopreservation Core Resource, University of Minnesota
• Devon D. Kelly, Director, OHSU Knight BioLibrary, Oregon Health & Science University, Knight Cancer Institute
• Bernard A. LaSalle, Director, Operations, BMIC, Biomedical Informatics, Center for Clinical and Translational Science, University of Utah
• Sylvia M. Lee, M.D., Medical Oncologist, Seattle Cancer Care Alliance
• Michael Liebman, Ph.D., Managing Director, IPQ Analytics, LLC
• Geoffrey P. Lomax, Ph.D., Senior Officer, Standards Working Group, California Institute for Regenerative Medicine
• James M. Olson, M.D., Ph.D., Member, Clinical Research Division, Fred Hutchinson Cancer Research Center; Professor, Pediatric Hematology and Oncology, University of Washington; Attending Physician, Seattle Children’s Hospital;  Founder, Presage Biosciences and Blaze Bioscience
• Bruce Pharr, Vice President, Life Science Research Systems, Remedy Informatics
• Nathan D. Price, Ph.D., Associate Director, Institute for Systems Biology
• Shannon Sewards, Associate Director, Human Subjects Division, University of Washington
• Stephen Schmechel, M.D., Ph.D., Associate Professor, UW Medicine Pathology, University of Washington
• John T. Slattery, Ph.D., Vice Dean, Research and Graduate Education, School of Medicine and Professor, Pharmacology and Medicine, University of Washington School of Medicine
• Stephanie Elaine Soares, MS, CCRP, Research Administrator, Urology, University of California Davis
• Suzane Vercauteren, M.D., Ph.D., FRCPC, Head, Division of Hematopathology, BC Children’s Hospital and Clinical  Assistant Professor, Pathology and Laboratory Medicine, University of British Columbia
• Amelia Wall Warner, President and CEO, Gentris
• Wendell G. Yarbrough, M.D., MMHC, FACS, Professor of Surgery, Otolaryngology and Pathology; Section Chief,  Otolaryngology; Co-Director, Molecular Virology Research Program; Director, Head and Neck Cancer Program,
• Smilow Cancer Hospital, Yale University
• William H. Yong, M.D., Professor, Pathology and Laboratory Medicine, Neuropathologist, National Neurologic AIDS Bank Director, Brain Tumor Translational Resource David Geffen School of Medicine, University of  California, Los Angeles

 Claire Zhu, Ph.D., Program Director, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health 

SOURCE

From: Leaders in Biobanking Congress <kerris@healthtech.com>
Date: Tue, 20 May 2014 13:43:27 -0400
To: <avivalev-ari@alum.berkeley.edu>